Sponsor
1 Diet beverages and the risk of obesity, diabetes, and cardiovascular disease: a review of the evidence Nutrition Reviews, May 7, 2013 Review Article
2 Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials British Medical Journal, April 25, 2013 Evidence Based Medicine Review Article
3 Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial The Lancet, May 16, 2013
4 Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report Cardiovascular Diabetology, May 15, 2013
5 Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women Journal of Clinical Endocrinology and Metabolism, May 8, 2013
6 Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Childrens Oncology Group phase 1 consortium study The Lancet Oncology, April 24, 2013
7
Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study
The Journal of Rheumatology, May 2, 2013
Exclusive Author Commentary
8 Vitamin D and depression in geriatric primary care patients Clinical Interventions in Aging, May 6, 2013
9 Diabetes mellitus and prostate cancer risk Cancer Epidemiology, Biomarkers & Prevention, May 23, 2013
10 Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer Annals of Oncology, May 21, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor